ThetaRay
PrivateLast Round
Growth Equity
Sep 5, 2023
Total Funding Raised
$148.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ThetaRay operates in FinTech and is based in Hod HaSharon. Its latest recorded funding round was a Growth Equity round in September 2023.
ThetaRay is a fintech software company that provides AI-driven anti-money laundering and financial crime compliance solutions for banks, fintechs, and payment service providers.
Sector
FinTech
Verticals
Compliance & Risk, Digital Payments, RegTech, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThetaRay Comparables
Compare ThetaRay with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hawk | 88% | |
| ComplyAdvantage | 86% | |
| Napier AI | 85% |
For institutional investors. Book with your work email.
ThetaRay Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 5, 2023 | ||||
| Series C | May 18, 2021 | ||||
| Series B | Jul 3, 2018 | ||||
| Corporate Funding | Dec 1, 2015 | ||||
| Series A | Jul 28, 2014 | ||||
Strategic | Aug 5, 2013 |
For institutional investors. Book with your work email.
ThetaRay Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JVP | Growth Equity, Strategic, Series B, Series A, Series C |
| Saints Capital | Series C |
| ABN AMRO Ventures | Series B |
| Jerusalem Venture Partners | Growth Equity, Corporate Funding, Series B, Series A, Series C, Seed |
| High House Investment | Series C |
| Poalim Equity | Corporate Funding, Series A |
| Bank Hapoalim | Series B, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 31% MoM to 11.5K.
- Apr 27, 2026
Now a $100M+ ARR business.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asNov 6, 2026
Euromoney recognizes ThetaRay for technology excellence and verifiable performance, while Chartis Research ranks it #8 globally in the Financial Crime and Compliance50 (FCC50) 2026 report and names it a Category Winner for Explainable AI.
- attends_eventNov 6, 2026
ThetaRay earns the world's best software provider recognition for AML and sanctions screening at the Euromoney Transaction Banking Awards 2026.
- recognized_asNov 6, 2026
ThetaRay is recognized as Best RegTech Solution at Finovate as part of its industry recognition.
- recognized_asNov 6, 2026
ThetaRay is named the world's best software provider for AML and sanctions screening at the Euromoney Transaction Banking Awards 2026.
- recognized_asNov 6, 2026
Chartis Research names ThetaRay a Category Winner for Explainable AI in its FCC50 2026 report, while Euromoney’s editorial and research team recognizes the company for technology excellence, verifiable performance, and advancing the modern transaction banking value chain.
For institutional investors. Book with your work email.
ThetaRay Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ThetaRay's valuation, stock price, and market status.
Is ThetaRay a public or private company?
ThetaRay is a private company.
What is the current stock price of ThetaRay?
ThetaRay is a private company, so its shares have no public market price. Caplight tracks ThetaRay's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ThetaRay worth (valuation)?
Valuation information for ThetaRay is not publicly available.
Can I buy ThetaRay stock?
ThetaRay shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ThetaRay's last funding round?
ThetaRay's most recent funding round was Growth Equity on September 5, 2023.
Who are the main investors in ThetaRay?
Key investors in ThetaRay include JVP, Jerusalem Venture Partners, Portage, Benhamou Global Ventures.
Will ThetaRay IPO soon?
No public IPO plans have been announced for ThetaRay.
How can I track ThetaRay secondary market activity?
Caplight tracks bids, offers, and trades in ThetaRay's shares on secondary markets.